These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32871695)

  • 1. Regulation of cannabinoid CB
    Salort G; Hernández-Hernández E; García-Fuster MJ; García-Sevilla JA
    J Affect Disord; 2020 Nov; 276():626-635. PubMed ID: 32871695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of IRAS/nischarin and other potential I
    Keller B; García-Sevilla JA
    J Affect Disord; 2017 Jan; 208():646-652. PubMed ID: 27836117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder.
    Jernigan CS; Goswami DB; Austin MC; Iyo AH; Chandran A; Stockmeier CA; Karolewicz B
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1774-9. PubMed ID: 21635931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of cannabinoid CB1 receptor and associated signaling networks in brains of cocaine addicts and cocaine-treated rodents.
    Álvaro-Bartolomé M; García-Sevilla JA
    Neuroscience; 2013 Sep; 247():294-308. PubMed ID: 23727505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression analysis of novel genes in the prefrontal cortex of major depressive disorder subjects.
    Goswami DB; Jernigan CS; Chandran A; Iyo AH; May WL; Austin MC; Stockmeier CA; Karolewicz B
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():126-33. PubMed ID: 23261523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective up-regulation of cannabinoid CB
    Mato S; Pilar-Cuéllar F; Valdizán EM; González-Maeso J; Rodríguez-Puertas R; Meana J; Sallés J; Crespo-Facorro B; Pazos Á
    Biochem Pharmacol; 2018 Nov; 157():258-265. PubMed ID: 30099006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc transporters protein level in postmortem brain of depressed subjects and suicide victims.
    Rafalo-Ulinska A; Piotrowska J; Kryczyk A; Opoka W; Sowa-Kucma M; Misztak P; Rajkowska G; Stockmeier CA; Datka W; Nowak G; Szewczyk B
    J Psychiatr Res; 2016 Dec; 83():220-229. PubMed ID: 27661418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposite regulation of cannabinoid CB1 and CB2 receptors in the prefrontal cortex of rats treated with cocaine during adolescence.
    García-Cabrerizo R; García-Fuster MJ
    Neurosci Lett; 2016 Feb; 615():60-5. PubMed ID: 26797579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of GRK 2 and 6, beta-arrestin-2 and associated proteins in the prefrontal cortex of drug-free and antidepressant drug-treated subjects with major depression.
    Grange-Midroit M; García-Sevilla JA; Ferrer-Alcón M; La Harpe R; Huguelet P; Guimón J
    Brain Res Mol Brain Res; 2003 Mar; 111(1-2):31-41. PubMed ID: 12654503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FADD adaptor and PEA-15/ERK1/2 partners in major depression and schizophrenia postmortem brains: basal contents and effects of psychotropic treatments.
    García-Fuster MJ; Díez-Alarcia R; Ferrer-Alcón M; La Harpe R; Meana JJ; García-Sevilla JA
    Neuroscience; 2014 Sep; 277():541-51. PubMed ID: 25075716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.
    Schatz AR; Lee M; Condie RB; Pulaski JT; Kaminski NE
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):278-87. PubMed ID: 9070350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased α2- and β1-adrenoceptor densities in postmortem brain of subjects with depression: differential effect of antidepressant treatment.
    Rivero G; Gabilondo AM; García-Sevilla JA; La Harpe R; Callado LF; Meana JJ
    J Affect Disord; 2014; 167():343-50. PubMed ID: 25020269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression pattern of the cannabinoid receptor genes in the frontal cortex of mood disorder patients and mice selectively bred for high and low fear.
    Choi K; Le T; McGuire J; Xing G; Zhang L; Li H; Parker CC; Johnson LR; Ursano RJ
    J Psychiatr Res; 2012 Jul; 46(7):882-9. PubMed ID: 22534181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of mTOR in depression and antidepressant responses.
    Abelaira HM; Réus GZ; Neotti MV; Quevedo J
    Life Sci; 2014 Apr; 101(1-2):10-4. PubMed ID: 24582593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parallel molecular alteration between Alzheimer's disease and major depressive disorder in the human brain dorsolateral prefrontal cortex: an insight from gene expression and methylation profile analyses.
    Rastad S; Barjaste N; Lanjanian H; Moeini A; Kiani F; Masoudi-Nejad A
    Genes Genet Syst; 2023 Apr; 97(6):311-324. PubMed ID: 36928034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of N-arachidonoyl-l-serine on human cerebromicrovascular endothelium.
    Kino T; Tomori T; Abutarboush R; Castri P; Chen Y; Lenz FA; McCarron RM; Spatz M
    Biochem Biophys Rep; 2016 Dec; 8():254-260. PubMed ID: 28955964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular inflammatory and antioxidant pathways in postmortem frontal cortex of subjects with major depression: effect of antidepressants.
    Martín-Hernández D; Caso JR; Javier Meana J; Callado LF; Madrigal JLM; García-Bueno B; Leza JC
    J Neuroinflammation; 2018 Sep; 15(1):251. PubMed ID: 30180869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of D1R/PKA/mTOR signaling cascade in medial prefrontal cortex underlying the antidepressant effects of l-SPD.
    Zhang B; Guo F; Ma Y; Song Y; Lin R; Shen FY; Jin GZ; Li Y; Liu ZQ
    Sci Rep; 2017 Jun; 7(1):3809. PubMed ID: 28630404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential roles of CB1 and CB2 cannabinoid receptors in mast cells.
    Samson MT; Small-Howard A; Shimoda LM; Koblan-Huberson M; Stokes AJ; Turner H
    J Immunol; 2003 May; 170(10):4953-62. PubMed ID: 12734338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of cannabinoid CB
    Salort G; Álvaro-Bartolomé M; García-Sevilla JA
    Psychopharmacology (Berl); 2017 Mar; 234(6):925-941. PubMed ID: 28127623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.